The Advisory Board Company (ABCO) : American Capital Management Inc scooped up 47,235 additional shares in The Advisory Board Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 3, 2016. The investment management firm now holds a total of 764,915 shares of The Advisory Board Company which is valued at $31,698,078.The Advisory Board Company makes up approximately 2.53% of American Capital Management Inc’s portfolio.
Other Hedge Funds, Including , Diam Ltd. added ABCO to its portfolio by purchasing 95,691 company shares during the most recent quarter which is valued at $3,965,435. The Advisory Board Company makes up approx 0.06% of Diam Ltd.’s portfolio.Riverbridge Partners reduced its stake in ABCO by selling 75,020 shares or 3.3% in the most recent quarter. The Hedge Fund company now holds 2,198,700 shares of ABCO which is valued at $91,114,128. The Advisory Board Company makes up approx 1.83% of Riverbridge Partners’s portfolio. Stonebridge Capital Management Inc sold out all of its stake in ABCO during the most recent quarter. The investment firm sold 15,860 shares of ABCO which is valued $588,406. Franklin Street Advisors Inc Nc sold out all of its stake in ABCO during the most recent quarter. The investment firm sold 17,300 shares of ABCO which is valued $680,582.
The Advisory Board Company closed down -0.43 points or -1.02% at $41.54 with 2,10,342 shares getting traded on Monday. Post opening the session at $42.09, the shares hit an intraday low of $41.36 and an intraday high of $42.51 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
On the company’s financial health, The Advisory Board Company reported $0.47 EPS for the quarter, beating the analyst consensus estimate by $ 0.13 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.34. The company had revenue of $198.40 million for the quarter, compared to analysts expectations of $196.49 million. The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.40 EPS.
Many Wall Street Analysts have commented on The Advisory Board Company. The Advisory Board Company was Upgraded by Craig Hallum to ” Buy” on Jul 28, 2016. Company shares were Reiterated by FBR Capital on Jul 28, 2016 to “Mkt Perform”, Firm has raised the Price Target to $ 37 from a previous price target of $35 .The Advisory Board Company was Downgraded by Raymond James to ” Mkt Perform” on Jul 19, 2016.
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues including physician alignment and engagement network management and growth strategy value-based care and population health revenue cycle clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management academic programming and student learning faculty recruitment and retention student advising and success alumni affairs and advancement and college and university operations. The Company offers approximately 65 distinct membership programs across four areas which include best practices research and insight performance technology software consulting and management services and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.